<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
xmlns:rawvoice="http://www.rawvoice.com/rawvoiceRssModule/"
>

<channel>
	<title>Medical Educator - Medical students, revise for your OSCE medical student exam with our free MCQs, EMQs, videos, podcasts, downloads. &#187; Research</title>
	<atom:link href="http://medicaleducator.co.uk/tag/research/feed" rel="self" type="application/rss+xml" />
	<link>http://medicaleducator.co.uk</link>
	<description>Medical students - get help passing and revise for your medical student exams with our multi choice questions (MCQs/EMQs), videos, podcasts and downloads. Free resources give it a trial!</description>
	<lastBuildDate>Mon, 30 Jan 2012 19:08:59 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=</generator>
<!-- podcast_generator="Blubrry PowerPress/2.0.2" -->
	<itunes:summary>Medical students - medical exam revision - free podcasts. More @ http://www.medicaleducator.co.uk</itunes:summary>
	<itunes:author>Medical Educator</itunes:author>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:image href="http://medicaleducator.co.uk/blog/podcasts/podcast.gif" />
	<itunes:owner>
		<itunes:name>Medical Educator</itunes:name>
		<itunes:email>medicale@medicaleducator.co.uk</itunes:email>
	</itunes:owner>
	<managingEditor>medicale@medicaleducator.co.uk (Medical Educator)</managingEditor>
	<copyright>2009</copyright>
	<itunes:subtitle>Medical Students: Get help and revision tips for passing your exams.</itunes:subtitle>
	<itunes:keywords>medical, student, finals, exam, revision, osce,</itunes:keywords>
	<image>
		<title>Medical Educator - Medical students, revise for your OSCE medical student exam with our free MCQs, EMQs, videos, podcasts, downloads. &#187; Research</title>
		<url>http://medicaleducator.co.uk/blog/podcasts/podcast_sm.gif</url>
		<link>http://medicaleducator.co.uk</link>
	</image>
	<itunes:category text="Science &amp; Medicine">
		<itunes:category text="Medicine" />
	</itunes:category>
	<itunes:category text="Education">
		<itunes:category text="Education Technology" />
	</itunes:category>
	<itunes:category text="Science &amp; Medicine" />
		<item>
		<title>Routes into disease research: Live Q&amp;A chat this afternoon 18.10.10</title>
		<link>http://medicaleducator.co.uk/routes-into-disease-research-live-qa-chat-this-afternoon-18-10-10.html</link>
		<comments>http://medicaleducator.co.uk/routes-into-disease-research-live-qa-chat-this-afternoon-18-10-10.html#comments</comments>
		<pubDate>Mon, 18 Oct 2010 06:44:02 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[medical exam questions]]></category>
		<category><![CDATA[career]]></category>
		<category><![CDATA[chat]]></category>
		<category><![CDATA[disease]]></category>
		<category><![CDATA[guardian]]></category>
		<category><![CDATA[into]]></category>
		<category><![CDATA[live]]></category>
		<category><![CDATA[Q&A]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[routes]]></category>
		<category><![CDATA[theguardian]]></category>
		<category><![CDATA[web]]></category>

		<guid isPermaLink="false">http://medicaleducator.co.uk/?p=794</guid>
		<description><![CDATA[The Guardian&#8217;s Alison White is hosting another live web chat on the topic of routes into disease research with a select panel of academic contributors from the MRC, Cancer Research UK, a selection of University lecturers and other healthcare professionals with a research interest. You can log on from here, and the live web chat [...]]]></description>
			<content:encoded><![CDATA[<p>The Guardian&#8217;s Alison White is hosting another live web chat on the topic of routes into disease research with a select panel of academic contributors from the MRC, Cancer Research UK, a selection of University lecturers and other healthcare professionals with a research interest.<a href="http://medicaleducator.co.uk/blog/wp-content/uploads/2010/10/guardian.png"><img class="size-full wp-image-795 aligncenter" title="guardian" src="http://medicaleducator.co.uk/blog/wp-content/uploads/2010/10/guardian.png" alt="" width="352" height="57" /></a></p>
<p>You can log on from <a href="http://careers.guardian.co.uk/forums?plckForumPage=ForumDiscussion&amp;plckDiscussionId=Cat%3afbe1954f-19a7-4006-82a3-08b5319f4c1dForum%3a7296f258-6ce7-4743-b359-795e7661e245Discussion%3a7bc47166-bbd6-43b6-8b46-7e7c87822600&amp;plckCurrentPage=0">here</a>, and the live web chat is open from 1pm-4pm today.</p>
<p style="text-align: center;">
]]></content:encoded>
			<wfw:commentRss>http://medicaleducator.co.uk/routes-into-disease-research-live-qa-chat-this-afternoon-18-10-10.html/feed</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Almetuzamab: Promise in Multiple Sclerosis; UK Research</title>
		<link>http://medicaleducator.co.uk/almetuzamab-promise-in-multiple-sclerosis-uk-research.html</link>
		<comments>http://medicaleducator.co.uk/almetuzamab-promise-in-multiple-sclerosis-uk-research.html#comments</comments>
		<pubDate>Sat, 25 Oct 2008 12:37:21 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[New Research]]></category>
		<category><![CDATA[almetuzamab]]></category>
		<category><![CDATA[MS]]></category>
		<category><![CDATA[multiple]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[sclerosis]]></category>

		<guid isPermaLink="false">http://medicaleducator.co.uk/blog/?p=86</guid>
		<description><![CDATA[Published this week in the New England Journal of Medicine, promising trial data for the new monoclonal antibody Almetuzamab.The conclusions of the study were as follows: &#8220; In patients with early, relapsing–remitting multiple sclerosis, alemtuzumab was more effective than interferon beta-1a but was associated with autoimmunity, most seriously manifesting as immune thrombocytopenic purpura. The study [...]]]></description>
			<content:encoded><![CDATA[<p>Published this week in the New England Journal of Medicine, promising trial data for the new monoclonal antibody Almetuzamab.The conclusions of the study were as follows:</p>
<p><em>&#8220;<span style="font-family: arial,helvetica;"> In patients with early, relapsing–remitting<sup> </sup>multiple sclerosis, alemtuzumab was more effective than interferon<sup> </sup>beta-1a but was associated with autoimmunity, most seriously<sup> </sup>manifesting as immune thrombocytopenic purpura. The study was<sup> </sup>not powered to identify uncommon adverse events.&#8221;</span></em></p>
<p>NEJM abstract link <a title="Alemtuzamab" href="http://content.nejm.org/cgi/content/short/359/17/1786" target="_blank">here</a></p>
<p>There has been extensive media coverage of the drug on UK media sources including coverage of patients who have received the drug. Cambridge researchers showed a reduction in relapse rate and disability in 334 patients suffering from multiple sclerosis for less than 3 years.</p>
]]></content:encoded>
			<wfw:commentRss>http://medicaleducator.co.uk/almetuzamab-promise-in-multiple-sclerosis-uk-research.html/feed</wfw:commentRss>
		<slash:comments>3</slash:comments>
		</item>
	</channel>
</rss>

